What does the evidence say about Panax Ginseng Cognition Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Panax Ginseng Cognition Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Methods We performed a systematic review and meta-analysis to quantitatively synthesize randomized controlled trial evidence on the efficacy of phytotherapeutic interventions for cancer-related fatigue and to assess the certainty of evidence. [Matsas S (2026); evidence level 1] - We also evaluated risk of bias (RoB 2), publication bias, and certainty of evidence using GRADE. [Matsas S (2026); evidence level 1] - Most trials had high or unclear risk of bias, and the certainty of evidence was rated very low. [Matsas S (2026); evidence level 1] - Background Cancer-related fatigue (CRF) is one of the most common and burdensome symptoms faced by patients with cancer, yet effective drug-based treatments remain limited. [Matsas S (2026); evidence level 1] - Ginsenosides are the prime pharmacologically active compounds responsible for the medicinal properties of ginseng, which are also found in many otherspecies, includingand. [Cortés Hernán (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.